Harihar Medical Agencies Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 14 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.13 Cr
- Revenue Growth 2303.55%
- Profit Growth 9381.62%
- Ebitda 4007.24%
- Net Worth 1416.38%
- Total Assets 682.27%
About Harihar Medical Agencies
Harihar Medical Agencies Private Limited (HMAPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 05 October 2010 and has a history of 14 years and four months. Its registered office is in Ranchi, Jharkhand, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹3.13 Cr.
Baby Sharma, Ramesh Sharma, and Nitish Kumar serve as directors at the Company.
Company Details
- Location
Ranchi, Jharkhand, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232JH2010PTC014444
- Company No.
014444
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Oct 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jharkhand
Industry
Who are the key members and board of directors at Harihar Medical Agencies?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Baby Sharma  | Managing Director | 05-Oct-2010 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nitish Kumar | Director | 05-Oct-2010 | Current |
| Ramesh Sharma | Director | 05-Oct-2010 | Current |
Financial Performance of Harihar Medical Agencies.
Harihar Medical Agencies Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 2303.55% increase. The company also saw a substantial improvement in profitability, with a 9381.62% increase in profit. The company's net worth Soared by an impressive increase of 1416.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Harihar Medical Agencies?
In 2021, Harihar Medical Agencies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹3.13 Cr
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 3.13 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Jan 2011 | Bank Of India | ₹3.13 Cr | Open |
How Many Employees Work at Harihar Medical Agencies?
Unlock and access historical data on people associated with Harihar Medical Agencies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Harihar Medical Agencies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Harihar Medical Agencies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.